Clinical Trial Update: A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis

View source ↗

Summary

A 5-year longitudinal observational study of patients with primary biliary cholangitis has completed, sponsored by Target PharmaSolutions, Inc. The document not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Snippet

Sponsor: Target PharmaSolutions, Inc. | Conditions: Biliary Cirrhosis, Primary | Status: COMPLETED